WebJan 10, 2024 · BMS acquired repotrectinib through its $4.1 billion acquisition of Turning Point Therapeutics last June. ... as patent expirations loom. "We are here [at the JP Morgan Healthcare Conference] because we are looking for partners," said Dean Li, president of Merck Research Laboratories. "We encourage all of these partners to come see us …
Bristol-Myers Squibb Co. (BMY) J.P. Morgan 41st Annual …
WebJan 10, 2024 · Bristol Myers Squibb will throw in as much as $3 billion for Century Therapeutics' cell therapies and is doling out at least $70 million for ArsenalBio's. … Web在2024年JPM大会上,BMS着重传递的信息便是努力在专利悬崖背景下实现增长,宣布将在2024年至2024年期间用约500亿美元现金流加码内外部创新管线。 在今年的JPM大会上,BMS公司执行副总裁兼首席商务官Chris Boerner继续对外阐述了该公司度过专利悬崖的重 … unexpectedly vs unexpectantly
JPMorgan Chase Q1 23 Earnings Conference Call At 8:30 AM ET
WebJan 10, 2024 · 40th Annual J.P. Morgan Healthcare Conference. January 10, 2024 03:00 PM ET. Add to Calendar. Add to Apple Calendar; Add to Google Calendar; Add to Microsoft Outlook; Add to iCalendar; Presentation (opens in new window) PDF 822 KB; Transcript (opens in new window) PDF 154 KB; Email Alerts. WebJan 11, 2024 · JPM Kicked Off with Fresh News from Pfizer, BMS, Illumina and Novavax. Published: Jan 11, 2024 By Alex Keown. Artur Widak/NurPhoto via Getty Images. The 2024 virtual J.P. Morgan Healthcare Conference got off to a roaring start Monday with deal announcements and plans to drive biopharma companies through the coming year. WebJan 9, 2024 · Bristol-Myers Squibb Co. (NYSE:BMY) J.P. Morgan 41st Annual Healthcare Conference Call January 9, 2024 10:30 AM ETCompany Participants. Chris Boerner - … unexpected max schenzel